Tredje AP-fonden’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-55,932
| Closed | -$12.6M | – | 537 |
|
|
2026
Q1 | $12.6M | Buy |
55,932
+41,231
| +280% | +$10.3M | 0.07% | 267 |
|
|
2025
Q4 | $3.54M | Hold |
14,701
| – | – | 0.03% | 212 |
|
|
2025
Q3 | $4.02M | Buy |
14,701
+3,237
| +28% | +$884K | 0.03% | 164 |
|
|
2025
Q2 | $2.96M | Hold |
11,464
| – | – | 0.02% | 173 |
|
|
2025
Q1 | $2.57M | Hold |
11,464
| – | – | 0.02% | 196 |
|
|
2024
Q4 | $2.62M | Sell |
11,464
-11,463
| -50% | -$2.76M | 0.02% | 232 |
|
|
2024
Q3 | $5.6M | Hold |
22,927
| – | – | 0.05% | 193 |
|
|
2024
Q2 | $4.39M | Sell |
22,927
-361
| -2% | -$73.2K | 0.04% | 201 |
|
|
2024
Q1 | $4.61M | Sell |
23,288
-25,970
| -53% | -$4.76M | 0.05% | 210 |
|
|
2023
Q4 | $8.47M | Buy |
49,258
+38,258
| +348% | +$5.88M | 0.11% | 141 |
|
|
2023
Q3 | $1.63M | Hold |
11,000
| – | – | 0.02% | 411 |
|
|
2023
Q2 | $2.4M | Buy |
+11,000
| New | +$2.45M | 0.03% | 342 |
|
|
2022
Q4 | – | Sell |
-4,725
| Closed | -$1.03M | – | 549 |
|
|
2022
Q3 | $1.03M | Hold |
4,725
| – | – | 0.02% | 459 |
|
|
2022
Q2 | $991K | Hold |
4,725
| – | – | 0.02% | 296 |
|
|
2022
Q1 | $1.15M | Hold |
4,725
| – | – | 0.02% | 310 |
|
|
2021
Q4 | $1.23M | Buy |
+4,725
| New | +$1.23M | 0.02% | 319 |
|
|
2020
Q1 | – | Sell |
-2,298
| Closed | -$356K | – | 376 |
|
|
2019
Q4 | $356K | Sell |
2,298
-1,128
| -33% | -$163K | 0.02% | 372 |
|
|
2019
Q3 | $463K | Sell |
3,426
-2,294
| -40% | -$301K | 0.02% | 368 |
|
|
2019
Q2 | $698K | Sell |
5,720
-4,238
| -43% | -$469K | 0.03% | 349 |
|
|
2019
Q1 | $1.03M | Buy |
9,958
+1,860
| +23% | +$192K | 0.05% | 294 |
|
|
2018
Q4 | $922K | Buy |
8,098
+5,569
| +220% | +$597K | 0.06% | 287 |
|
|
2018
Q3 | $292K | Sell |
2,529
-4,595
| -65% | -$503K | 0.01% | 375 |
|
|
2018
Q2 | $738K | Sell |
7,124
-28,846
| -80% | -$2.92M | 0.03% | 369 |
|
|
2018
Q1 | $3.54M | Buy |
35,970
+4,650
| +15% | +$439K | 0.13% | 200 |
|
|
2017
Q4 | $2.65M | Buy |
31,320
+21,620
| +223% | +$1.79M | 0.09% | 262 |
|
|
2017
Q3 | $747K | Sell |
9,700
-12,000
| -55% | -$918K | 0.03% | 464 |
|
|
2017
Q2 | $1.69M | Sell |
21,700
-16,640
| -43% | -$1.19M | 0.06% | 346 |
|
|
2017
Q1 | $2.76M | Sell |
38,340
-5,328
| -12% | -$368K | 0.11% | 240 |
|
|
2016
Q4 | $2.71M | Sell |
43,668
-232
| -0.5% | -$14.2K | 0.11% | 230 |
|
|
2016
Q3 | $2.84M | Buy |
43,900
+19,010
| +76% | +$1.27M | 0.13% | 198 |
|
|
2016
Q2 | $1.57M | Buy |
24,890
+21,930
| +741% | +$1.29M | 0.07% | 262 |
|
|
2016
Q1 | $170K | Buy |
+2,960
| New | +$168K | 0.01% | 373 |
|
Other funds holding RMD
Tredje AP-fonden's RMD Position: Q2 2026 in Review
Tredje AP-fonden sold out of ResMed (RMD) in Q2 2026, closing a stake of 55,932 shares — an estimated $12.6M sold.
Tredje AP-fonden first reported a position in RMD in Q1 2016 and held it in 32 quarters. The position peaked at $12.6M in Q1 2026. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Tredje AP-fonden reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
- Tredje AP-fonden sold 55,932 ResMed shares in Q2 2026, an estimated $12.6M.
- Tredje AP-fonden first reported a position in ResMed in Q1 2016 and held it in 32 quarters.
- Tredje AP-fonden's ResMed position peaked at $12.6M in Q1 2026.
- 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.